Form 8-K - Current report:
SEC Accession No. 0001171843-26-001838
Filing Date
2026-03-23
Accepted
2026-03-23 07:31:10
Documents
13
Period of Report
2026-03-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_032026.htm   iXBRL 8-K 14919
2 PRESS RELEASE exh_991.htm EX-99.1 68416
  Complete submission text file 0001171843-26-001838.txt   291213

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE gnw-20250101.xsd EX-101.SCH 3402
4 XBRL DEFINITION FILE gnw-20250101_def.xml EX-101.DEF 26066
5 XBRL LABEL FILE gnw-20250101_lab.xml EX-101.LAB 35956
6 XBRL PRESENTATION FILE gnw-20250101_pre.xml EX-101.PRE 24702
16 EXTRACTED XBRL INSTANCE DOCUMENT f8k_032026_htm.xml XML 2840
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 26779901
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)